Joshua M Eizen An2 Therapeutics, Inc. (ANTX) insider trading activity

Joshua M Eizen is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 152,499 shares of ANTX, which is worth approximately $173,848. The most recent transaction as insider was on Jan 06, 2026, when has been sold 6,931 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $7,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K

12.94% 3M change

30.71% 12M change

Total Value Held $173,848

Joshua M Eizen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2026	SELL Open market or private sale	$7,000 $1.01 p/Share	6,931 Reduced 4.35%	152,499 Common Stock
Jan 05 2026	SELL Open market or private sale	$17,923 $1.0 p/Share	17,923 Reduced 10.11%	159,430 Common Stock
Nov 04 2025	SELL Open market or private sale	$3,213 $1.14 p/Share	2,819 Reduced 1.56%	177,353 Common Stock
Feb 26 2025	BUY Grant, award, or other acquisition	-	58,500 Added 25.04%	175,172 Common Stock
Jan 03 2025	SELL Open market or private sale	$12,948 $1.34 p/Share	9,663 Reduced 7.65%	116,672 Common Stock
Nov 04 2024	BUY Grant, award, or other acquisition	-	31,500 Added 19.96%	126,335 Common Stock
Jul 10 2024	BUY Grant, award, or other acquisition	-	60,000 Added 38.75%	94,833 Common Stock

Mar 15 2024	BUY Grant, award, or other acquisition	-	30,000 Added 48.04%	32,447 Common Stock

JME

Joshua M Eizen

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Value

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to AN2 Therapeutics, Inc.

Track Activities on ANTX

Account